Larimar Therapeutics, Inc.
LRMR- 交易所
- Nasdaq
- 產業
- Pharmaceutical Preparations
- SEC CIK
- 0001374690
近 90 天,Larimar Therapeutics, Inc. 內部人申報 9 筆公開市場買進、0 筆賣出;2026 年第 3 季末有 146 家機構在 13F 申報持有,市值合計 $3.33 億;沒有大師持有。
SEC 申報
Larimar Therapeutics, Inc. 向 SEC 申報的 10-K、10-Q、8-K、20-F、40-F,最新的在前。
Livermore 只列出每份申報的表單、8-K 的 Item 與日期。內文請到 SEC 網站讀;8-K 的新聞稿等附件(例如 Item 2.02 的 EX-99.1)在申報目錄裡。
| 申報日 | 表單 | 8-K 的 Item | 期間 | 原文 | 申報目錄 |
|---|---|---|---|---|---|
| 2026/11/16 | 10-Q | – | 2026/9/30 | SEC | 目錄 |
| 2026/11/16 | 8-K | 2.029.01 | 2026/11/16 | SEC | 目錄 |
| 2026/11/9 | 8-K | 2.028.019.01 | 2026/11/9 | SEC | 目錄 |
| 2026/9/29 | 8-K | 5.02 | 2026/9/29 | SEC | 目錄 |
| 2026/8/4 | 10-Q | – | 2026/6/30 | SEC | 目錄 |
| 2026/8/4 | 8-K | 2.028.019.01 | 2026/8/4 | SEC | 目錄 |
| 2026/6/29 | 8-K | 8.019.01 | 2026/6/29 | SEC | 目錄 |
| 2026/5/19 | 8-K | 5.07 | 2026/5/19 | SEC | 目錄 |
| 2026/5/14 | 10-Q | – | 2026/3/31 | SEC | 目錄 |
| 2026/5/14 | 8-K | 2.028.019.01 | 2026/5/14 | SEC | 目錄 |
| 2026/3/19 | 10-K | – | 2025/12/31 | SEC | 目錄 |
| 2026/3/19 | 8-K | 2.029.01 | 2026/3/19 | SEC | 目錄 |
| 2026/3/9 | 8-K | 8.019.01 | 2026/3/9 | SEC | 目錄 |
| 2026/2/27 | 8-K | 1.019.01 | 2026/2/25 | SEC | 目錄 |
| 2026/2/24 | 8-K | 8.019.01 | 2026/2/24 | SEC | 目錄 |
| 2026/1/22 | 8-K | 3.025.039.01 | 2026/1/21 | SEC | 目錄 |
| 2026/1/12 | 8-K | 2.028.019.01 | 2026/1/12 | SEC | 目錄 |
| 2025/12/17 | 8-K | 3.025.039.01 | 2025/12/16 | SEC | 目錄 |
| 2025/11/10 | 8-K | 8.019.01 | 2025/11/10 | SEC | 目錄 |
| 2025/11/5 | 10-Q | – | 2025/9/30 | SEC | 目錄 |
| 2025/11/5 | 8-K | 2.029.01 | 2025/11/5 | SEC | 目錄 |
| 2025/10/14 | 8-K | 8.019.01 | 2025/10/14 | SEC | 目錄 |
| 2025/9/29 | 8-K | 8.019.01 | 2025/9/29 | SEC | 目錄 |
| 2025/8/14 | 10-Q | – | 2025/6/30 | SEC | 目錄 |
| 2025/8/14 | 8-K | 2.028.019.01 | 2025/8/14 | SEC | 目錄 |
| 2025/7/31 | 8-K | 1.019.01 | 2025/7/29 | SEC | 目錄 |
| 2025/7/29 | 8-K | 2.02 | 2025/7/29 | SEC | 目錄 |
| 2025/6/23 | 8-K | 8.019.01 | 2025/6/23 | SEC | 目錄 |
| 2025/6/23 | 8-K | 8.019.01 | 2025/6/23 | SEC | 目錄 |
| 2025/5/13 | 8-K | 5.07 | 2025/5/13 | SEC | 目錄 |
| 2025/5/5 | 8-K | 8.019.01 | 2025/5/5 | SEC | 目錄 |
| 2025/4/30 | 10-Q | – | 2025/3/31 | SEC | 目錄 |
| 2025/4/30 | 8-K | 2.029.01 | 2025/4/30 | SEC | 目錄 |
| 2025/3/24 | 10-K | – | 2024/12/31 | SEC | 目錄 |
| 2025/3/24 | 8-K | 2.028.019.01 | 2025/3/24 | SEC | 目錄 |
| 2025/1/27 | 8-K | 5.029.01 | 2025/1/22 | SEC | 目錄 |
| 2025/1/10 | 8-K | 8.019.01 | 2025/1/10 | SEC | 目錄 |
| 2024/12/16 | 8-K | 8.019.01 | 2024/12/16 | SEC | 目錄 |
| 2024/11/18 | 8-K | 8.019.01 | 2024/11/18 | SEC | 目錄 |
| 2024/10/30 | 10-Q | – | 2024/9/30 | SEC | 目錄 |
| 2024/10/30 | 8-K | 2.028.019.01 | 2024/10/30 | SEC | 目錄 |
| 2024/8/8 | 10-Q | – | 2024/6/30 | SEC | 目錄 |
| 2024/8/7 | 8-K | 2.028.019.01 | 2024/8/7 | SEC | 目錄 |
| 2024/6/10 | 8-K | 8.019.01 | 2024/6/10 | SEC | 目錄 |
| 2024/5/31 | 8-K | 5.07 | 2024/5/29 | SEC | 目錄 |
| 2024/5/30 | 8-K | 8.019.01 | 2024/5/30 | SEC | 目錄 |
| 2024/5/20 | 8-K | 8.019.01 | 2024/5/20 | SEC | 目錄 |
| 2024/5/9 | 10-Q | – | 2024/3/31 | SEC | 目錄 |
| 2024/5/9 | 8-K | 2.028.019.01 | 2024/5/9 | SEC | 目錄 |
| 2024/3/14 | 10-K | – | 2023/12/31 | SEC | 目錄 |